Expression of nuclear factor erythroid 2 protein in malignant cutaneous tumors

Chang Yong Choi1, Jin Young Kim1, Seo Yeong Wee1

  • 1Department of Plastic and Reconstructive Surgery, Soonchunhyang Gumi Hospital, Soonchunhyang University College of Medicine, Gumi, Korea.

Archives of Plastic Surgery
|November 15, 2014
PubMed
Abstract

Insights

Nuclear factor E2-related factor (Nrf2) protects against oxidative damage. This study found decreased Nrf2 protein expression in malignant melanoma, squamous cell carcinoma, and basal cell carcinoma, suggesting a link to skin cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatology

Background:

  • Reactive oxygen species (ROS) cause cellular damage and alter signaling.
  • Nuclear factor E2-related factor (Nrf2) is a key regulator protecting cells from oxidative stress.
  • Nrf2 is upregulated in many cancers, but its role in skin cancers is under-investigated.

Purpose of the Study:

  • To investigate the expression of Nrf2 protein in various human skin cancers.
  • To compare Nrf2 levels in malignant melanoma, squamous cell carcinoma, and basal cell carcinoma with normal skin tissues.

Main Methods:

  • Western blotting and immunohistochemical staining were used to analyze Nrf2 protein expression.
  • The study included 24 specimens: 6 malignant melanomas (MM), 6 squamous cell carcinomas (SCC), 6 basal cell carcinomas (BCC), and 6 normal skin samples.
  • Expression of Kelch-like ECH-associated protein 1 (Keap1), a key Nrf2 regulator, was also assessed.

Main Results:

  • Nrf2 protein was confirmed and detected in normal skin tissues.
  • Nrf2 expression was significantly decreased in all examined skin cancer types (MM, SCC, BCC) compared to normal skin.
  • Keap1 showed no expression in either malignant skin tumors or normal skin tissues via western blot.

Conclusions:

  • The study demonstrates down-regulation of Nrf2 protein in human malignant skin tumors.
  • Decreased Nrf2 expression is suggested to be associated with the pathogenesis of skin cancers.
  • Further research into the role of Nrf2 in skin cancer is warranted.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.5K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
8.1K
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.2K